Anticorps Monoclonal anti-Calsequestrin 2

Calsequestrin 2 Monoclonal Antibody for WB, IHC, IF-P, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, porc, rat, souris

Applications

WB, IHC, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1C10A1

N° de cat : 66419-1-PBS

Synonymes

Calsequestrin 2, CASQ2, PDIB2



Informations sur le produit

66419-1-PBS cible Calsequestrin 2 dans les applications de WB, IHC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc, rat, souris

Réactivité Humain, porc, rat, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène Calsequestrin 2 Protéine recombinante Ag13246
Nom complet calsequestrin 2 (cardiac muscle)
Masse moléculaire calculée 46 kDa
Poids moléculaire observé 50 kDa
Numéro d’acquisition GenBankBC022288
Symbole du gène Calsequestrin 2
Identification du gène (NCBI) 845
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Calsequestrin (CASQ) is a Ca2+-binding protein present primarily in junctional sarcoplasmic reticulum of skeletal and cardiac muscle; the cardiac form (CASQ2) is encoded by a separate gene. The primary role of CASQ2 is buffering of the sarcoplasmic reticulum Ca2+ ions, but another role for CASQ2 has emerged recently: CASQ2 regulates the open probability of ryanodine receptor 2 (RyR2). Mutations in CASQ2 cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest.

{{ptg:RelatedPrimaryAntibodies}}